Table of Contents Author Guidelines Submit a Manuscript
Bone Marrow Research
Volume 2016, Article ID 5043483, 4 pages
http://dx.doi.org/10.1155/2016/5043483
Research Article

Role of Microvessel Density and Vascular Endothelial Growth Factor in Angiogenesis of Hematological Malignancies

1Department of Pathology, Himalayan Institute of Medical Sciences, Swami Ram Nagar, Doiwala, Dehradun, Uttarakhand 248140, India
2Department of Medicine, Himalayan Institute of Medical Sciences, Swami Ram Nagar, Doiwala, Dehradun, Uttarakhand 248140, India

Received 17 November 2015; Revised 1 January 2016; Accepted 14 January 2016

Academic Editor: Paolo De Fabritiis

Copyright © 2016 Rashika Chand et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. J. Giles, “The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies,” Oncologist, vol. 6, no. 5, pp. 32–39, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. U. Gianelli, C. Vener, P. R. Raviele et al., “VEGF expression correlates with microvessel density in Philadelphia chromosome—negative chronic myeloproliferative disorders,” American Journal of Clinical Pathology, vol. 128, no. 6, pp. 966–973, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Schneider, I. Dubus, F. Gouel, E. Legrand, J. P. Vannier, and M. Vasse, “What role for angiogenesis in childhood acute lymphoblastic leukaemia?” Advances in Hematology, vol. 2011, Article ID 274628, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M.-T. Krauth, I. Simonitsch, K. J. Aichberger et al., “Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease,” American Journal of Clinical Pathology, vol. 121, no. 4, pp. 473–481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C.-L. Ho, B. Arora, J. D. Hoyer, L. E. Wellik, R. A. Mesa, and A. Tefferi, “Bone marrow expression of vascular endothelial growth factor in myelofibrosis with myeloid metaplasia,” European Journal of Haematology, vol. 74, no. 1, pp. 35–39, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Nagy, A. M. Dvorak, and H. F. Dvorak, “VEGF-A and the induction of pathological angiogenesis,” Annual Review of Pathology, vol. 2, pp. 251–275, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. T. P. Stricker and V. Kumar, “Neoplasia,” in Robbins and Cotran Pathologic Basis of Disease, V. Kumar, A. K. Abbas, N. Fausto, and J. C. Aster, Eds., Saunders Elsevier, Philadelphia, Pa, USA, 8th edition, 2010. View at Google Scholar
  8. J. Ridgway, G. Zhang, Y. Wu et al., “Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis,” Nature, vol. 444, no. 7122, pp. 1083–1087, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. El-Sorady, M. A. Elrahman, M. El-Bordini, A. El-Ghandour, A. El-Said, and A. Deghady, “Bone marrow angiogenesis in patients with hematological malignancies: role of VEGF,” Journal of the Egyptian National Cancer Institute, vol. 12, pp. 131–136, 2000. View at Google Scholar
  10. M. Medinger and K. Mross, “Clinical trials with anti-angiogenic agents in hematological malignancies,” Journal of Angiogenesis Research, vol. 2, article 10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Aguayo, H. Kantarjian, T. Manshouri et al., “Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes,” Blood, vol. 96, no. 6, pp. 2240–2245, 2000. View at Google Scholar · View at Scopus